Page 64 - CJO_F17_GLAUCOMA_SUPPLEMENT
P. 64

C  CLINICAL RESEARCH



               ferentiation of normal from glaucomatous eyes. Arch Ophthalmol.   69.  Kim C, Seong GJ, Lee N, Song K, Society KG, Namil Study Group.
                  2006;124(11):1579-1583.                      Prevalence of primary open-angle glaucoma in central south korea:
               46.  Sihota R, Srinivasan G, Dada T, Gupta V, Ghate D, Sharma A. Is the   The namil study. Ophthalmology. 2011;118(6):1024-1030.
                  ISNT rule violated in early primary open-angle glaucoma—a scan-  70.  Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glau-
                  ning laser tomography study. Eye. 2008;22(6):819-824.  coma in japan--a nationwide glaucoma survey. Jpn J Ophthalmol.
               47.  Jonas JB, Budde WM. Diagnosis and pathogenesis of glaucoma-  1991;35(2):133-155.
                  tous optic neuropathy: Morphological aspects. Prog Retin Eye Res.   71.  Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family his-
                  2000;19(1):1-40.                             tory and risk of primary open angle glaucoma: The baltimore eye
               48.  Chong GT, Lee RK. Glaucoma versus red disease: Imaging and   survey. Arch Ophthalmol. 1994;112(1):69-73.
                  glaucoma diagnosis. Curr Opin Ophthalmol. 2012;23(2):79-88.  72.  Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman
               49.  Wong E, Yoshioka N, Kalloniatis M, Zangerl B. Cirrus HD-OCT   A, de Jong PT. Genetic risk of primary open-angle glaucoma:
                  short-term repeatability of clinical retinal nerve fiber layer mea-  Population-based familial aggregation study. Arch Ophthalmol.
                  surements. Optom Vis Sci. 2015;92(1):83-88.  1998;116(12):1640-1645.
               50.  Hart WM, Becker B. The onset and evolution of glaucomatous   73.  Brandt JD, Beiser JA, Kass MA, Gordon MO, Ocular Hyperten-
                  visual field defects. Ophthalmology. 1982;89(3):268-279.  sion Treatment Study (OHTS) Group. Central corneal thickness in
               51.  Kerrigan–Baumrind LA, Quigley HA, Pease ME, Kerrigan DF,   the ocular hypertension treatment study (OHTS). Ophthalmology.
                  Mitchell RS. Number of ganglion cells in glaucoma eyes compared   2001;108(10):1779-1788.
                  with threshold visual field tests in the same persons. Invest Oph-  74.  Francis BA, Varma R, Chopra V, et al. Intraocular pressure, central
                  thalmol Vis Sci. 2000;41(3):741-748.         corneal thickness, and prevalence of open-angle glaucoma: The los
               52.  Artes PH, Chauhan BC, Keltner JL, et al. Longitudinal and   angeles latino eye study. Am J Ophthalmol. 2008;146(5):741-746.
                  cross-sectional analyses of visual field progression in participants   75.  Ocular Hypertension Treatment Study Group, European Glaucoma
                  of the ocular hypertension treatment study. Arch Ophthalmol.   Prevention Study Group. Validated prediction model for the devel-
                  2010;128(12):1528-1532.                      opment of primary open-angle glaucoma in individuals with ocular
               53.  Nouri-Mahdavi K, Nassiri N, Giangiacomo A, Caprioli J. Detection   hypertension. Ophthalmology. 2007;114(1):10-19. e2.
                  of visual field progression in glaucoma with standard achromatic   76.  Leske MC. Ocular perfusion pressure and glaucoma: Clinical trial
                  perimetry: A review and practical implications. Graefe’s Archive for   and epidemiologic findings. Curr Opin Ophthalmol. 2009;20(2):73-
                  Clinical and Experimental Ophthalmology. 2011;249(11):1593.  78.
               54.  Medeiros FA, Lisboa R, Weinreb RN, Girkin CA, Liebmann JM,   77.  Krasińska B, Karolczak-Kulesza M, Krasiński Z, et al. Effects of the
                  Zangwill LM. A combined index of structure and function for stag-  time of antihypertensive drugs administration on the stage of pri-
                  ing glaucomatous damage. Arch Ophthalmol. 2012;130(9):1107-1116.  mary open-angle glaucoma in patients with arterial hypertension.
               55.  Rao HL, Yadav RK, Addepalli UK, et al. Comparing spectral-  Blood Press. 2012;21(4):240-248.
                  domain optical coherence tomography and standard automated   78.  Quaid P, Simpson T, Freddo T. Relationship between diastolic per-
                  perimetry to diagnose glaucomatous optic neuropathy. J Glaucoma.   fusion pressure and progressive optic neuropathy as determined by
                  2015;24(5):e69-74.                           heidelberg retinal tomography topographic change AnalysisGlauco-
               56.  Leung CKS, Liu S, Weinreb RN, et al. Evaluation of retinal nerve   matous optic neuropathy predicted by HRT. Invest Ophthalmol Vis
                  fiber layer progression in glaucoma: A prospective analysis with   Sci. 2013;54(1):789-798.
                  neuroretinal rim and visual field progression. Ophthalmology.   79.  Xu L, Wang Y, Wang S, Wang Y, Jonas JB. High myopia and
                  2011;118(8):1551-1557.                       glaucoma susceptibility: The beijing eye study. Ophthalmology.
               57.  Chauhan BC, Garway-Heath DF, Goni FJ, et al. Practical recommen-  2007;114(2):216-220.
                  dations for measuring rates of visual field change in glaucoma. Br J   80.  Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship
                  Ophthalmol. 2008;92(4):569-573.              between glaucoma and myopia: The blue mountains eye study.
               58.  European Glaucoma Prevention Study (EGPS) Group. Predictive   Ophthalmology. 1999;106(10):2010-2015.
                  factors for open-angle glaucoma among patients with ocular hyper-  81.  Wang JJ, Mitchell P, Smith W. Is there an association between mi-
                  tension in the european glaucoma prevention study. Ophthalmology.   graine headache and open-angle glaucoma?: Findings from the blue
                  2007;114(1):3-9.                             mountains eye study. Ophthalmology. 1997;104(10):1714-1719.
               59.  Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R.   82.  Hashim S, Al Mansouri F, Farouk M, Al Hashemi A, Singh R. Preva-
                  The prevalence of glaucoma in a population-based study of hispanic   lence of glaucoma in patients with moderate to severe obstructive
                  subjects: Proyecto VER. Arch Ophthalmol. 2001;119(12):1819-1826.  sleep apnea: Ocular morbidity and outcomes in a 3 year follow-up
               60.  Hasegawa K, Ishida K, Sawada A, Kawase K, Yamamoto T. Diurnal   study. Eye. 2014;28(11):1304-1309.
                  variation of intraocular pressure in suspected normal-tension glau-  83.  Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension can-
                  coma. Jpn J Ophthalmol. 2006;50(5):449-454.  ada’s 2017 guidelines for diagnosis, risk assessment, prevention, and
               61.  Leske MC, Heijl A, Hyman L, et al. Predictors of long-term   treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557-
                  progression in the early manifest glaucoma trial. Ophthalmology.   576.
                  2007;114(11):1965-1972.                   84.  Mosaed S, Liu JH, Weinreb RN. Correlation between office and
               62.  Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors   peak nocturnal intraocular pressures in healthy subjects and glau-
                  for glaucomatous visual field progression in the advanced glaucoma   coma patients. Am J Ophthalmol. 2005;139(2):320-324.
                  intervention study. Ophthalmology. 2004;111(9):1627-1635.  85.  Kario K, Shimada K. Risers and extremeńdippers of nocturnal blood
               63.  Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of   pressure in hypertension: Antihypertensive strategy for nocturnal
                  intraocular pressure monitoring outside of normal office hours in   blood pressure. Clin Exp Hypertens. 2004;26(2):177-189.
                  patients with glaucoma. Arch Ophthalmol. 2006;124(6):793-797.  86.  Graham S, Drance S. Nocturnal hypotension: Role in glaucoma
               64.  Bagga H, Liu JH, Weinreb RN. Intraocular pressure measurements   progression. Surv Ophthalmol. 1999;43:S10-S16.
                  throughout the 24 h. Curr Opin Ophthalmol. 2009;20(2):79-83.  87.  Plange N, Kaup M, Daneljan L, Predel H, Remky A, Arend O. 24-h
               65.  Dinn RB, Zimmerman MB, Shuba LM, et al. Concordance of diurnal   blood pressure monitoring in normal tension glaucoma: Night-time
                  intraocular pressure between fellow eyes in primary open-angle   blood pressure variability. J Hum Hypertens. 2006;20(2):137-142.
                  glaucoma. Ophthalmology. 2007;114(5):915-920.  88.  Kang JH, Loomis SJ, Rosner BA, Wiggs JL, Pasquale LR. Com-
               66.  Friedman DS, Jampel HD, Munoz B, West SK. The prevalence of   parison of risk factor profiles for primary open-angle glaucoma
                  open-angle glaucoma among blacks and whites 73 years and older:   subtypes defined by pattern of visual field loss: A prospective
                  The salisbury eye evaluation glaucoma study. Arch Ophthalmol.   StudyDeterminants of POAG subtypes by visual field loss. Invest
                  2006;124(11):1625-1630.                      Ophthalmol Vis Sci. 2015;56(4):2439-2448.
               67.  Rotchford AP, Johnson GJ. Glaucoma in zulus: A population-based   89.  Jin SW, Seo HR, Rho SS, Rho SH. The effects of nocturnal dip and
                  cross-sectional survey in a rural district in south africa. Arch Oph-  blood pressure variability on paracentral scotoma in early open-
                  thalmol. 2002;120(4):471-478.                angle glaucoma. . 2016:1-7.
               68.  Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a   90.  Chervin RD, Guilleminault C. Obstructive sleep apnea and related
                  risk factor for progressive glaucomatous damage. Ann Ophthalmol.   disorders. Neurol Clin. 1996;14(3):583-609.
                  1985;17(10):653-659.                      91.  Surani SR. Diabetes, sleep apnea, obesity and cardiovascular



      64             CANADIAN JOURNAL of OPTOMETRY    |    REVUE CANADIENNE D’OPTOMÉTRIE    VOL. 79  SUPPLEMENT 1, 2017
   59   60   61   62   63   64   65   66   67   68   69